Stimulation of oncogene-specific tumor infiltrating T-cells through combined vaccine and alpha-PD1 enable sustained anti-tumor responses against established HER2 breast cancer (BC)

Cre-loxP-induced Ewsr1-Atf1 translocation tumors

Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy

Fat1 deletion promotes hybrid EMT state with enhanced tumor progression, stemness, and metastasis

A novel neural stem cell-derived immunocompetent mouse model of glioblastoma for preclinical studies (RNA-Seq)

In vivo adenine base editing of PCSK9 in mice and macaques reduces LDL-cholesterol levels [RNA-seq]

In vivo adenine base editing of PCSK9 in mice and macaques reduces LDL-cholesterol levels

Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune-regulatory features

Overcoming microenvironmental resistance to anti-PD-1 immunotherapy in lung cancer models

Identifying non-genetic determinants of malignant clonal fitness at single cell resolution

"Stripe" transcription factors provide accessibility to co-binding partners in mammalian genomes.

MeVa2.1.dOVA is a novel immune-refractory cell line to study tumor immune resistance

Effect of existence or depletion of LIN28B on gene expression during tumor growth of PDAC cells

A maternal-effect Padi6 variant causes nuclear and cytoplasmic abnormalities in oocytes as well 2 as failure of epigenetic reprogramming and zygotic genome activation in embryos

Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma.

RNA-Seq, WGS, WXS of mouse myeloma tumors derived from Vk*MYC transgenic mice

Conditionally Replicative Adenovirus as a Therapy for Malignant Peripheral Nerve Sheath Tumors

Neoantigen identification for 1956 and F244 murine MCA-sarcomas

COMPASS complex inhibition targets the metastasis initiating cell in undifferentiated pleomorphic sarcoma